Drug Topics Announces the Addition of RPhAlly to its Strategic Alliance Partnership Program

New Jersey, UNITED STATES


ISELIN, N.J., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Drug Topics®, the leading multimedia resource for pharmacy professionals, today announced it added RPhAlly to its Strategic Alliance Partnership (SAP) program.

Drug Topics Strategic Alliance Partnership Seal

“We are excited about working with RPhAlly as a partner to amplify availability of news and information by pharmacists for pharmacists to help the pharmacist community,” said William Mulderry, vice president, group publisher of Drug Topics® and Total Pharmacy®. “In a constantly changing health care environment, RPhAlly’s format as a social media community dovetails with the long-established position that Drug Topics® holds with pharmacists around their professional development.”

RPhAlly is an exclusive app-based platform for pharmacy professionals across the country. Its growing community includes engaged pharmacists seeking to advance their careers and the practice of pharmacy through support, education and opportunity. Within the mobile app, members can access a directory of colleagues, a lively discussion forum and pharmacy groups populated by peers.

“RPhAlly is uniting pharmacy through SEO: support, education and opportunities. We recognize that partnering with other champions of our profession is essential to reaching and benefitting as many colleagues as possible,” said Kevin Walker, co-owner and chief strategy officer at RPhAlly. “Drug Topics® is an established and trusted name and has consistently shown a genuine commitment to supporting pharmacy. Our partnership will help to catalyze the collaborative efforts required to address the significant concerns of our profession."

The Drug Topics® SAP program is a community of health care associations, societies and advocacy groups that foster collaboration and an open exchange of information among trusted peers for the benefit of patients and their families. These strategic partnerships aim to heighten Drug Topic®’s ability to distribute useful information and diversify the perspectives available to the patient-facing pharmacist universe.

For more information about the Drug Topics® SAP program, visit our website.

About RPhAlly

RPhAlly is focused on uniting and advancing the world of pharmacy. Our profession is at a critical juncture and needs to come together more than ever to create the future we all want, and patients deserve. Our platform was created for exactly that purpose. A place to support each other, educate and grow, and expand our opportunities to improve health care. Our thought leaders are here to help pharmacists and pharmacy technicians advance together, and we need you here to reimagine the profession and make it happen.

About Drug Topics®

Founded in 1857, Drug Topics® is the only magazine serving all pharmacists in the United States. The publication provides regular news, expert opinion, industry analysis, career guidance and peer perspectives. Drug Topics®’ continuing education, powered by AdvanCE™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Drug Topics® is a brand of MJH Life Sciences®, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

About Total Pharmacy®

Designed specifically for entrepreneurial pharmacists and independent pharmacy market stakeholders, Total Pharmacy® delivers resources to effectively maximize profits, minimize costs and improve the overall patient experience. Our mission is to redefine the value and standards of community pharmacy by providing trusted content and business solutions that drive measurable change in health care delivery. Total Pharmacy® is a brand of MJH Life Sciences®, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

Drug Topics® Media Contact
Lauren Biscaldi
editors@drugtopics.com